The engineering and regulatory roadmap to scale API & HPAPI from grams to commercial volume—without unexpected delays or costly batch failures.
Get the Technical Scale-Up Guide
Developed for CMC Directors, Process Chemists, and Sourcing Heads handling complex small molecule development. No generic marketing—pure technical execution.
Scaling an active ingredient isn’t linear. Minor thermodynamic deviations at the bench level routinely trigger massive yield drops and safety redesigns at 1,000+ liters.
Inside this technical playbook, you’ll find actionable data on:
- The 4 Lab-to-Reactor Blind Spots: Why standard mixing and heat transfer models collapse during scale-up, and the specific parameters you must monitor to de-risk pilot runs.
- HPAPI Containment Traps: Where budgets blow out during containment validation, and how to design high-potency isolation protocols that scale directly to commercial tonnage.
- The Multi-Vendor Tax: The financial and operational cost of splitting development across multiple CDMOs—and how repeated tech transfers stall timelines by an average of 3–6 months.
- The Single-Chain Framework: How AGC Pharma Chemicals—as an integrated CDMO for Small Molecule APIs and HPAPIs—combines Phase I process development through commercial manufacturing to ensure full yield retention and regulatory compliance.
